STOCK TITAN

HNGE (HNGE) shareholder details planned sale of 15,000 shares under Rule 144

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

HNGE has a shareholder filing a notice of proposed sale under Rule 144 for up to 15,000 shares of common stock. The shares are to be sold through Morgan Stanley Smith Barney LLC with an aggregate market value of $708,750.00, based on the information provided. The filing notes that 37,919,155 shares of this class were outstanding, and the approximate sale date listed is 12/22/2025 on the NYSE.

The 15,000 shares to be sold were acquired on 04/01/2023 as performance stock units from the issuer. Over the prior three months, the same account completed a Rule 10b5-1 sale of 15,000 common shares on 11/21/2025 for gross proceeds of $683,487.00. By signing the notice, the seller represents that they do not know of undisclosed material adverse information about the issuer’s operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the HNGE Form 144 filing disclose?

The notice discloses that a shareholder of HNGE intends to sell up to 15,000 shares of common stock under Rule 144, using Morgan Stanley Smith Barney LLC as broker, with an approximate sale date of 12/22/2025 on the NYSE.

How many HNGE shares are planned to be sold and what is their market value?

The filing lists 15,000 common shares of HNGE to be sold, with an aggregate market value of $708,750.00 based on the figures provided.

How were the HNGE shares being sold under Rule 144 acquired?

The 15,000 HNGE common shares were acquired on 04/01/2023 as performance stock units from the issuer, with the acquisition and payment date both shown as 04/01/2023.

How many HNGE shares of this class are outstanding?

The notice states that there are 37,919,155 shares of the relevant class of HNGE common stock outstanding at the time referenced.

What recent HNGE share sales has this seller made in the last three months?

The filing reports 10b5-1 sales for James Pursley of 15,000 HNGE common shares on 11/21/2025, generating $683,487.00 in gross proceeds.

What representation does the HNGE shareholder make in this Rule 144 notice?

By signing, the seller represents that they do not know any material adverse information about HNGE’s current or prospective operations that has not been publicly disclosed, and if relying on a Rule 10b5-1 plan, that this representation applies as of the plan’s adoption or instruction date.
Hinge Health, Inc.

NYSE:HNGE

HNGE Rankings

HNGE Latest News

HNGE Latest SEC Filings

HNGE Stock Data

3.83B
34.49M
8.08%
132.02%
1.61%
Health Information Services
Services-computer Processing & Data Preparation
Link
United States
SAN FRANCISCO